Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation

被引:14
|
作者
Rowinska, Zuzanna [1 ,2 ,3 ]
Koeppel, Thomas A. [4 ]
Sanati, Maryam [3 ]
Schelzig, Hubert [5 ]
Jankowski, Joachim [3 ,6 ]
Weber, Christian [7 ]
Zernecke, Alma [8 ]
Liehn, Elisa A. [3 ,9 ]
机构
[1] Ruhr Univ Bochum, St Josef Hosp, Dept Vasc Surg, Bochum, Germany
[2] Ruhr Univ Bochum, St Josef Hosp, Interdisciplinary Vein Ctr, Bochum, Germany
[3] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany
[4] Hosp Asklepios St Georg Hamburg, Div Vasc Surg, Hamburg, Germany
[5] Dusseldorf Univ Hosp, Dept Vasc & Endovasc Surg, Dusseldorf, Germany
[6] Maastricht Univ, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands
[7] Ludwig Maximilian Univ Munich, Inst Prevent & Epidemiol Cardiovasc Dis, Munich, Germany
[8] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany
[9] Univ Med & Pharm, Human Genet Lab, Craiova, Romania
来源
PLOS ONE | 2017年 / 12卷 / 02期
关键词
SMOOTH-MUSCLE-CELLS; ALLOGRAFT-REJECTION; LESION FORMATION; GROWTH-FACTOR; MOUSE MODELS; FRACTALKINE; CX(3)CR1; MICE; ARTERIOSCLEROSIS; ATHEROGENESIS;
D O I
10.1371/journal.pone.0170644
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The CX3C chemokine receptor CX3CR1 is expressed on monocytes as well as tissue resident cells, such as smooth muscle cells ( SMCs). Its role in atherosclerotic tissue remodeling of the aorta after transplantation has not been investigated. Methods We here have orthotopically transplanted infrarenal Cx3cr1(-/-) Apoe(-/-) and Cx3cr1(+/+) Apoe(-/-)aortic segments into Apoe(-/-) mice, as well as Apoe(-/-) aortic segments into Cx3cr1(-/-) Apoe(-/-)mice. The intimal plaque size and cellular plaque composition of the transplanted aortic segment were analyzed after four weeks of atherogenic diet. Results Transplantation of Cx3cr(-/-) Apoe(-/-) aortic segments into Apoe(-/-) mice resulted in reduced atherosclerotic plaque formation compared to plaque size in Apoe(-/-) or Cx3cr1(-/-) Apoe(-/-) mice after transplantation of Apoe(-/-) aortas. This reduction in lesion formation was associated with reduced numbers of lesional SMCs but not macrophages within the transplanted Cx3cr(-/-) Apoe(-/-) aortic segment. No differences in frequencies of proliferating and apoptotic cells could be observed. Conclusion These results indicate that CX3CR1 on resident vessel wall cells plays a key role in atherosclerotic plaque formation in transplanted aortic grafts. Targeting of vascular CX3CL1/ CX3CR1 may therefore be explored as a therapeutic option in vascular transplantation procedures.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
    Masztalewicz, Marta
    Nowacki, Przemystaw
    Szydlowski, Lukasz
    Zukowski, Maciej
    Gutowski, Piotr
    FOLIA NEUROPATHOLOGICA, 2017, 55 (02) : 174 - 181
  • [2] Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice
    Poupel, Lucie
    Boissonnas, Alexandre
    Hermand, Patricia
    Dorgham, Karim
    Guyon, Elodie
    Auvynet, Constance
    Saint Charles, Flora
    Lesnik, Philippe
    Deterre, Philippe
    Combadiere, Christophe
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) : 2297 - 2305
  • [3] Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands
    Goode-Romero, Guillermo
    Dominguez, Laura
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 117
  • [4] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186
  • [5] E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis
    Wakita, Hisashi
    Yanagawa, Tatsuya
    Kuboi, Yoshikazu
    Imai, Toshio
    MOLECULAR PHARMACOLOGY, 2017, 92 (05) : 502 - 509
  • [6] VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
    Low, Sarah
    Wu, Haixia
    Jerath, Kavita
    Tibolla, Annette
    Fogal, Birgit
    Conrad, Rebecca
    MacDougall, Margit
    Kerr, Steven
    Berger, Valentina
    Dave, Rajvee
    Villalona, Jorge
    Pantages, Lynn
    Ahlberg, Jennifer
    Li, Hua
    Van Hoorick, Diane
    Ververken, Cedric
    Broadwater, John
    Waterman, Alisa
    Singh, Sanjaya
    Kroe-Barrett, Rachel
    MABS, 2020, 12 (01)
  • [7] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Wojdasiewicz, Piotr
    Poniatowski, Lukasz A.
    Kotela, Andrzej
    Deszczynski, Jaroslaw
    Kotela, Ireneusz
    Szukiewicz, Dariusz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (05) : 395 - 403
  • [8] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Piotr Wojdasiewicz
    Łukasz A. Poniatowski
    Andrzej Kotela
    Jarosław Deszczyński
    Ireneusz Kotela
    Dariusz Szukiewicz
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 395 - 403
  • [9] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Apostolakis, Stavros
    Spandidos, Demetrios
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (10) : 1251 - 1256
  • [10] The Monocyte Chemokine Receptor CX3CR1 Does Not Play a Significant Role in the Pathogenesis of Experimental Autoimmune Uveoretinitis
    Kezic, Jelena
    McMenamin, Paul G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (10) : 5121 - 5127